iAluRil can be used in the treatment of:
Interstitial cystitis (IC)
Bladder pain syndrome (BPS)
Recurrent urinary tract
Chemical/radiation-induced cystitis (including BCG)
The lining of the bladder is known as the glycosaminoglycan, or GAG layer. This layer protects the inside of the bladder from bacteria and the irritants found in urine. There are four components that make up the GAG layer, but the two present in iAluRil are hyaluronic acid and chondroitin sulphate.
In certain bladder conditions, like BPS/IC and rUTIs, the GAG layer becomes damaged which means the bladder lining is unprotected. This can cause irritation and damage; resulting in pain. Nerve endings which are usually protected by the GAG layer may also become exposed; changing the signals sent to the brain about when to urinate; even a very small amount of urine in the bladder can feel like you’re about to burst. The risk of infection is also higher.
These GAG components attach together and have the ability to bind water; forming a gel-like layer to protect inside of the bladder.
The addition of calcium chloride is what makes iAluRil different. Calcium chloride stabilises the iAluRil solution and provides superior adhesive and protective properties.
Because iAluRil contains two GAG components; HA and CS, it is able to effectively replenish the damaged GAG layer. In doing so, the symptoms associated with bladder conditions; pain, urgency and frequency, may be alleviated and the risk of bacterial infection is significantly reduced .
A damaged GAG layer
iAluRil effectively replenishes the GAG layer
As a healthy GAG layer is made of more than one component, it follows that an effective therapy will contain a combination. iAluRil is the only GAG therapy to contain both HA and CS; a combination which allows a more effective replenishment of the GAG layer.
Not only is iAluRil the only combination GAG therapy, it is also the only one to contain 3 components. The addition of
calcium chloride (CaCl):
iAluRil has the most evidence of any GAG therapy, with the most clinical studies and high quality data from a range of different types of trials.⁵
Horkay, Ferenc et al. “Chondroitin Sulfate in Solution: Effects of Mono- and Divalent Salts.” Macromolecules vol. 45,6 (2012): 2882-2890. doi:10.1021/ma202693
Gribbon P, Heng BC, Hardingham TE. “The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association.’’ Biochem J. 2000 Aug 15;350 Pt 1:329-35.
Stellavato, Antonietta et al. “Hyaluronic acid and chondroitin sulfate, alone or in combination, efficiently counteract induced bladder cell damage and inflammation.’’ ESSM Poster, Ljubljana 2019
Zoppetti G, Puppini N, Pizzutti M. 2006 May 26; “Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis’’ EP2034956B1
Damiano R, et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic Acid and
chondroitin sulphate: a placebocontrolled randomised trial. Eur Urol. 2011 Apr; 59(4):64551. Epub 2011 Jan 18.